Narwhal Capital Management increases AmSurg stake by 2.6% — 3 notes

During the third quarter of fiscal year 2016, Narwhal Capital Management increased its stake in Nashville, Tenn.-based AmSurg by 2.6 percent, according to The Cerbat-Gem.

Advertisement

Here are three notes:

1. The firm had a nearly $1.1 million stake in AmSurg at the end of Q3.

2. Citigroup rated AmSurg shares a “buy” rating on Sept. 26, 2016.

3. Citigroup set a $79 price target on AmSurg shares.

More articles on surgery centers:
Ortho Montana, St. Vincent Healthcare & Yellowstone Surgery Center expand outpatient services through Montana Ambulatory Care Campus: 4 highlights
Teachers Advisors bolsters stake in AmSurg in Q3; Tenet to sell hospitals in noncore markets & more — 4 ASC company key notes
Top ASC liquidity analysis: 22 statistics on cash, accounts receivable & net working capital

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.